Abstract
Significant advances are needed to improve the diagnosis, prognosis, and management of persons with CKD. Discovery of new biomarkers and improvements in currently available biomarkers for CKD hold great promise to achieve these necessary advances. Interest in identification and evaluation of biomarkers for CKD has increased substantially over the past decade. In 2009, the National Institute of Diabetes and Digestive and Kidney Diseases established the CKD Biomarkers Consortium (http://www.ckdbiomarkersconsortium.org/), a multidisciplinary, collaborative study group located at over a dozen academic medical centers. The main objective of the consortium was to evaluate new biomarkers for purposes related to CKD in established prospective cohorts, including those enriched for CKD. During the first 5 years of the consortium, many insights into collaborative biomarker research were gained that may be useful to other investigators involved in biomarkers research. These lessons learned are outlined in this Special Feature and include a wide range of issues related to biospecimen collection, storage, and retrieval, and the internal and external quality assessment of laboratories that performed the assays. The authors propose that invest...Continue Reading
References
Feb 26, 2000·Diabetic Medicine : a Journal of the British Diabetic Association·C J SchultzD B Dunger
Mar 10, 2001·Clinical Pharmacology and Therapeutics·UNKNOWN Biomarkers Definitions Working Group.
Oct 12, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Rulan S ParekhUNKNOWN Family Investigation of Nephropathy and Diabetes Research Group
Citations
Nov 29, 2015·Clinical Journal of the American Society of Nephrology : CJASN·Patrick S ParfreyGlenn M Chertow
Jun 9, 2016·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Sushrut S WaikarUNKNOWN Chronic Kidney Disease Biomarkers Consortium Investigators
Apr 27, 2017·São Paulo Medical Journal = Revista Paulista De Medicina·Maria Alice Muniz DomingosSilvia Maria de Oliveira Titan
May 5, 2017·American Journal of Physiology. Renal Physiology·Jan WysockiMaryam Afkarian
Aug 2, 2017·Circulation. Cardiovascular Genetics·Kiran MusunuruUNKNOWN American Heart Association Committee on Molecular Determinants of Cardiovascular Health of the Council on Functional Genomic
Jan 18, 2018·Clinical Journal of the American Society of Nephrology : CJASN·Katherine G GarloDavid M Charytan
Dec 24, 2018·Clinical Journal of the American Society of Nephrology : CJASN·Eugene P RheeUNKNOWN CKD Biomarkers Consortium
Mar 4, 2017·Clinical Journal of the American Society of Nephrology : CJASN·Meyeon ParkUNKNOWN CKD Biomarkers Consortium
Jan 21, 2017·Journal of the American Society of Nephrology : JASN·Salem AlmaaniDaniel J Birmingham
Oct 13, 2019·Physiological Reports·Sheeba Ba AqeelUNKNOWN Diabetes Control, Complications Trial (DCCT)/Epidemiology of Diabetes Interventions, Complications (EDIC) Study
May 21, 2015·Clinical Chemistry·Kathleen D Liu, Chi-Yuan Hsu
May 20, 2020·Expert Review of Proteomics·Nathan BasistyBirgit Schilling
Apr 2, 2017·Expert Review of Proteomics·Jon B Klein
Jul 16, 2020·Health Research Policy and Systems·Gordon DugleWilm Quentin
Jan 7, 2021·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Aleksandra Stankovic
Dec 31, 2020·International Journal of Molecular Sciences·Irina LousaAlice Santos-Silva
Jul 25, 2021·International Journal of Molecular Sciences·Joanna Tracz, Magdalena Luczak
Oct 3, 2017·Journal of Proteome Research·Jenny Forshed